Together, these findings highlight the presence of coordinated transcriptional activity changes in HTN, shared regulators identified across both conditions included HNF4A, MYC, FOXO1 and STAT2, all exhibiting significant dysregulation (p < 0.05). The gene discussed is MYC; the disease is hypertensive disorder.